Search Results - "Bia, M.J"

The evolving experience using everolimus in clinical transplantation by Formica, R.N, Lorber, K.M, Friedman, A.L, Bia, M.J, Lakkis, F, Smith, J.D, Lorber, M.I

“…Everolimus is a derivative of sirolimus, a macrocyclic lactone, originally isolated from Streptomyces hygroscopicus. Both everolimus and sirolimus have a…”
Get full text

Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers used for the treatment of hypertension appear to be safe in the early posttransplant period by Formica, R.N., Friedman, A.L., Lorber, M.I., Bia, M.J.

“…Angiotensin II converting enzyme inibitors (ACE) and angiotensin II receptor blockers (ARB) are frequently avoided as treatment for hypertension in the early…”
Get full text

Sirolimus-based immunosuppression with reduce dose cyclosporine or tacrolimus after renal transplantation by Formica, R.N, Lorber, K.M, Friedman, A.L, Bia, M.J, Lakkis, F, Smith, J.D, Lorber, M.I

“…Sirolimus (SRL), a fermentation product of Streptomyces hygroscopicus, complexes with the FKBP12 to inhibit cyclin dependent kinase(s), collectively termed the…”
Get full text

The evolving role of tor inhibitors for individualizing posttransplant immunosuppression by Lorber, M.I., Basadonna, G.P., Friedman, A.L., Lorber, K.M., Bia, M.J., Formica, R., Smith, J.D.

Get full text

Body size mismatch between donor and recipient and the development of chronic rejection in renal transplantation by Lee, L.S., Auersvald, L.A., Claus, E.B., Bia, M.J., Friedman, A.L., Lorber, M.I., Basadonna, G.P.

Get full text